News & Announcements
September 23, 2019 - Claritas Rx Supports Swim a Mile for Women with Cancer
Claritas Rx is excited to support the local charity event Swim a Mile for Women with Cancer, happening October 5th & 6th at Mills College in Oakland. This annual event is run by the non-profit Women's Cancer Resource Center, whose mission is to create opportunities for women with cancer to improve their quality of life through education, supportive services, and practical assistance.
Cancer treatments represent nearly half of the therapies in the Claritas customer portfolio. We support cancer treatment every day and supporting WCRC is one more way for us to positively impact patients.
Come join the Claritas Rx team on October 5th & 6th in raising money for a good cause! Click here to make your donation to the Claritas Rx swim team.
About Women's Cancer Research Center
WCRC helps people with cancer navigate through the often overwhelming health care system so that they can get the appropriate care and treatment they need. They support people of all backgrounds, ethnicities, and incomes, but primarily serve low-income women and minorities – populations that typically face formidable barriers to accessing health information, preventive care, treatment, and emotional/social support.
February 5, 2019 - Claritas Rx Announces Expansion of Advisory Board
Claritas Rx LLC, a data integration and analytics company focused on specialty biopharmaceutical products, announced today the expansion of its Advisory Board with two key appointments: Vita Cassese and Steven Fitzpatrick.
“Claritas Rx continues to position itself for sustainable growth and scale consistent with our strategic plan,” commented Michael Fitzgibbons, CEO of Claritas Rx. “Vita’s operational experience in biopharma companies, combined with her expertise in strategy for technology companies, will provide us with a valuable perspective. Steve’s deep expertise in the specialty pharmacy industry will be an asset to our board given our focus on the patient experience in specialty and orphan therapeutic areas.”
Read the press release here and meet our expanded Advisory Board here.
November 12, 2018 - Claritas Rx Team impacted by Butte County fire
The Claritas Rx team is deeply saddened by the impact of the Camp Fire raging in Butte County, CA. Our treasured project coordinator extraordinaire, Dawn Durfee, and her family, were evacuated last Thursday from their home in Paradise, and today they confirmed that they lost everything in the fire. The real challenge is getting support during this time when insurance and FEMA support is not known. Please consider a donation to the Durfees during this trying time:
Any questions can be directed to an email account set up specifically for this: email@example.com
September 5, 2018 - Claritas Rx CEO Mike Fitzgibbons to Speak at 2018 AVBCC Summit
Claritas Rx Founder and CEO Mike Fitzgibbons will be speaking at the 2018 Association for Value-Based Cancer Care (AVBCC) Summit in New York City on October 30th. He will be speaking on a panel entitled "Optimizing Patient Services Solutions in Cancer Care", moderated by Douglas Bock, Partner, Archbow Consulting.
View the AVBCC Summit agenda here.
Claritas Rx, LLC
July 15, 2018 - Claritas Mentioned in Forbes Magazine Article
Claritas Rx was mentioned in the July 13, 2018 article in Forbes Magazine entitled "Understanding Data Aggregation in the Pharmacy Industry". Click the link below to read the article and learn more about how companies like Claritas Rx can help biopharmaceutical companies understand the patient journey in their specialty market.
Read the article here.
July 5, 2016 - Claritas Rx Announces Formation of Advisory Board
Claritas Rx LLC, a data integration and analytics company focused on specialty biopharmaceutical products, announced today the formation of its Advisory Board with two key appointments: Kurt Hilzinger, CPA and Dr. Kent Lieginger. As advisors, they will provide strategic and operational insight to help Claritas navigate our growing business and optimize the solutions we offer our customers.
Learn more about our advisors here.